UK's Human Fertilisation & Embryology Act 2008 in force
This article was originally published in Clinica
Executive Summary
The Human Fertilisation and Embryology Act 2008 came into force on October 1. The review of its predecessor, the Human Fertilisation and Embryology Act 1990, was conducted in large measure to reflect technological developments, and is "particularly important with regards to stem cell regulation and research", according to the UK's BioIndustry Association. The government described the legislation as "ensuring that the UK remains at the forefront of scientific advances in this field". The Act "ensures regulation of human-admixed embryos, created from a combination of human and animal genetic material for stem cell research".
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.